President Trump's foreign aid freeze has halted funding for vital H.I.V. programs, risking the health of 20 million people worldwide. While subsequent waivers have allowed some continuation of work, the necessary funds and legal documents remain unavailable. The $7.5 billion PEPFAR program, critical since 2003, is particularly affected. Experts warn that failure to resume aid could erase progress against H.I.V., creating severe health crises and possibly increasing drug-resistant infections. With U.S.A.I.D. operating at reduced capacity, hopes for quick resolution seem bleak, underscoring urgent needs in global health response.
Without treatment, millions of people with H.I.V. would be at risk of severe illness and premature death, jeopardizing the progress made in recent years.
The pause on aid and the stripping down of U.S.A.I.D. have delivered a system shock to global health efforts, particularly in H.I.V. treatment.
Collection
[
|
...
]